Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,414 | 5,556 | 3,319 | 1,336 | 6,014 |
| Depreciation Amortization | 2,773 | 1,960 | 1,121 | 264 | 607 |
| Income taxes - deferred | -549 | -374 | -174 | N/A | N/A |
| Accounts receivable | 502 | 287 | 429 | 323 | 110 |
| Accounts payable and accrued liabilities | -1,213 | -439 | -174 | 345 | 52 |
| Other Working Capital | 1,562 | 639 | 129 | 1,140 | 484 |
| Other Operating Activity | 876 | 230 | -203 | -644 | -110 |
| Operating Cash Flow | $11,365 | $7,859 | $4,447 | $2,764 | $7,157 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -247 | -196 | -158 | -19 | -1,532 |
| Net Acquisitions | -41,084 | -41,084 | -41,084 | -41,084 | N/A |
| Purchase Of Investment | -500 | -500 | -500 | -500 | -1,600 |
| Sale Of Investment | 15,155 | 15,155 | 15,155 | 15,155 | 5,839 |
| Purchase Sale Intangibles | -10 | -8 | -7 | -5 | -2 |
| Other Investing Activity | -9 | -8 | -7 | -4 | -2 |
| Investing Cash Flow | $-26,685 | $-26,633 | $-26,594 | $-26,452 | $2,705 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 26,934 | 26,934 | 26,934 | 26,934 | N/A |
| Debt Repayment | -5,942 | -3,682 | -1,927 | -132 | -413 |
| Common Stock Issued | 485 | 442 | 375 | 36 | 425 |
| Common Stock Repurchased | N/A | 0 | N/A | N/A | -439 |
| Dividend Paid | -3,433 | -1,705 | -851 | N/A | -6,030 |
| Other Financing Activity | 34 | 30 | 24 | 11 | 38 |
| Financing Cash Flow | $18,078 | $22,019 | $24,555 | $26,849 | $-6,419 |
| Exchange Rate Effect | -41 | -23 | 41 | 30 | -35 |
| Beginning Cash Position | 3,818 | 3,818 | 3,818 | 3,818 | 410 |
| End Cash Position | 6,534 | 7,040 | 6,267 | 7,008 | 3,818 |
| Net Cash Flow | $2,717 | $3,222 | $2,449 | $3,190 | $3,408 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,365 | 7,859 | 4,447 | 2,764 | 7,157 |
| Capital Expenditure | -247 | -196 | -158 | -19 | -1,532 |
| Free Cash Flow | 11,118 | 7,663 | 4,289 | 2,745 | 5,625 |